AN OPEN-LABEL STUDY OF FAMOTIDINE AS A TREATMENT FOR SCHIZOPHRENIA

被引：0
|
作者：
WHITEFORD, HA
STEDMAN, TJ
MCGRATH, JJ
WELHAM, J
POND, S
机构：
来源：
JOURNAL OF PSYCHIATRY & NEUROSCIENCE | 1995年 / 20卷 / 03期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：239 / 240
页数：2
相关论文
共 50 条
  • [1] AN OPEN-LABEL STUDY OF FAMOTIDINE AS A TREATMENT FOR SCHIZOPHRENIA - REPLY
    OYEWUMI, LK
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 1995, 20 (03): : 240 - 240
  • [2] AN OPEN-LABEL STUDY OF THE THERAPEUTIC EFFICACY OF HIGH-DOSE FAMOTIDINE ADJUVANT PHARMACOTHERAPY IN SCHIZOPHRENIA
    ROSSE, RB
    KENDRICK, KA
    FAYMCCARTHY, M
    COLLINS, JP
    ROSENBERG, PB
    WYATT, RJ
    DEUTSCH, SI
    SCHIZOPHRENIA RESEARCH, 1995, 15 (1-2) : 148 - 148
  • [3] An open-label study of the therapeutic efficacy of high-dose famotidine adjuvant pharmacotherapy in schizophrenia: Preliminary evidence for treatment efficacy
    Rosse, RB
    Kendrick, K
    FayMcCarthy, M
    Prell, GD
    Rosenberg, P
    Tsui, LC
    Wyatt, RJ
    Deutsch, SI
    CLINICAL NEUROPHARMACOLOGY, 1996, 19 (04) : 341 - 348
  • [4] Olanzapine in treatment-refractory schizophrenia: Results of an open-label study
    Martin, J
    Gomez, JC
    GarciaBernardo, E
    Cuesta, M
    Alvarez, E
    Gurpegui, M
    JOURNAL OF CLINICAL PSYCHIATRY, 1997, 58 (11) : 479 - 483
  • [5] Minocycline as Adjunctive Therapy for Schizophrenia: An Open-Label Study
    Miyaoka, Tsuyoshi
    Yasukawa, Rei
    Yasuda, Hideaki
    Hayashida, Maiko
    Inagaki, Takuji
    Horiguchi, Jun
    CLINICAL NEUROPHARMACOLOGY, 2008, 31 (05) : 287 - 292
  • [6] Minocycline as Adjunctive Therapy for Schizophrenia: An Open-Label Study
    Miyaoka, Tsuyoshi
    BIOLOGICAL PSYCHIATRY, 2009, 65 (08) : 91S - 91S
  • [7] -Lipoic Acid as Adjunctive Treatment for Schizophrenia: An Open-Label Trial
    Olivier Sanders, Lia Lira
    de Souza Menezes, Carlos Eduardo
    Maia Chaves Filho, Adriano Jose
    Viana, Glautemberg de Almeida
    Fechine, Francisco Vagnaldo
    Rodrigues de Queiroz, Maria Goretti
    da Cruz Fonseca, Said Goncalvez
    Mendes Vasconcelos, Silvania Maria
    Amaral de Moraes, Maria Elisabete
    Gama, Clarissa S.
    Seybolt, Sheila
    Campos, Eugenio de Moura
    Macedo, Danielle
    de Lucena, David Freitas
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2017, 37 (06) : 697 - 701
  • [8] Quetiapine ('Seroquel') and olanzapine for acute treatment of patients with schizophrenia: An open-label, comparative study
    Reznik, I
    Slavkin, L
    Shabash, E
    Shaked, G
    Kertzman, S
    Spivak, B
    Weizman, A
    Kotler, M
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S244 - S244
  • [9] Nefazodone in the adjunctive therapy of schizophrenia: An open-label exploratory study
    Rosenberg, PB
    Rosse, RB
    Schwartz, BL
    Deutsch, SI
    CLINICAL NEUROPHARMACOLOGY, 2000, 23 (04) : 222 - 225
  • [10] An open-label study of quetiapine in the treatment of fibromyalgia
    Hidalgo, Javier
    Rico-Villademoros, Fernando
    Calandre, Elena Pita
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2007, 31 (01): : 71 - 77
12345